nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—HTR2A—pancreatitis	0.585	1	CbGaD
Paliperidone—Rash papular—Hyoscyamine—pancreatitis	0.00759	0.0376	CcSEcCtD
Paliperidone—Sinus tachycardia—Hyoscyamine—pancreatitis	0.00702	0.0348	CcSEcCtD
Paliperidone—Salivary hypersecretion—Propantheline—pancreatitis	0.00537	0.0266	CcSEcCtD
Paliperidone—Balance disorder—Hyoscyamine—pancreatitis	0.00517	0.0256	CcSEcCtD
Paliperidone—Electrocardiogram QT prolonged—Hyoscyamine—pancreatitis	0.00441	0.0218	CcSEcCtD
Paliperidone—Thirst—Propantheline—pancreatitis	0.00421	0.0209	CcSEcCtD
Paliperidone—Mania—Hyoscyamine—pancreatitis	0.00389	0.0193	CcSEcCtD
Paliperidone—Ventricular arrhythmia—Hyoscyamine—pancreatitis	0.00382	0.0189	CcSEcCtD
Paliperidone—Stupor—Hyoscyamine—pancreatitis	0.00379	0.0188	CcSEcCtD
Paliperidone—Laryngospasm—Hyoscyamine—pancreatitis	0.00379	0.0188	CcSEcCtD
Paliperidone—Ventricular fibrillation—Hyoscyamine—pancreatitis	0.00369	0.0183	CcSEcCtD
Paliperidone—Dysphagia—Propantheline—pancreatitis	0.00347	0.0172	CcSEcCtD
Paliperidone—Erectile dysfunction—Propantheline—pancreatitis	0.00319	0.0158	CcSEcCtD
Paliperidone—Dysarthria—Hyoscyamine—pancreatitis	0.00299	0.0148	CcSEcCtD
Paliperidone—Muscle twitching—Hyoscyamine—pancreatitis	0.00288	0.0143	CcSEcCtD
Paliperidone—Blood pressure increased—Hyoscyamine—pancreatitis	0.00283	0.014	CcSEcCtD
Paliperidone—Ventricular tachycardia—Hyoscyamine—pancreatitis	0.00283	0.014	CcSEcCtD
Paliperidone—Injection site reaction—Hyoscyamine—pancreatitis	0.00281	0.0139	CcSEcCtD
Paliperidone—Depressed level of consciousness—Hyoscyamine—pancreatitis	0.00273	0.0135	CcSEcCtD
Paliperidone—Photophobia—Hyoscyamine—pancreatitis	0.00266	0.0132	CcSEcCtD
Paliperidone—Dry eye—Hyoscyamine—pancreatitis	0.00261	0.0129	CcSEcCtD
Paliperidone—Flushing—Propantheline—pancreatitis	0.00258	0.0128	CcSEcCtD
Paliperidone—Hypertonia—Hyoscyamine—pancreatitis	0.00248	0.0123	CcSEcCtD
Paliperidone—Hyperkinesia—Hyoscyamine—pancreatitis	0.00247	0.0122	CcSEcCtD
Paliperidone—Tension—Propantheline—pancreatitis	0.00237	0.0117	CcSEcCtD
Paliperidone—Nervousness—Propantheline—pancreatitis	0.00235	0.0116	CcSEcCtD
Paliperidone—Swelling—Hyoscyamine—pancreatitis	0.00233	0.0115	CcSEcCtD
Paliperidone—Eczema—Hyoscyamine—pancreatitis	0.00228	0.0113	CcSEcCtD
Paliperidone—Vision blurred—Propantheline—pancreatitis	0.00228	0.0113	CcSEcCtD
Paliperidone—Nasal congestion—Hyoscyamine—pancreatitis	0.00225	0.0112	CcSEcCtD
Paliperidone—Atrial fibrillation—Hyoscyamine—pancreatitis	0.00217	0.0107	CcSEcCtD
Paliperidone—Thirst—Hyoscyamine—pancreatitis	0.00216	0.0107	CcSEcCtD
Paliperidone—Palpitations—Propantheline—pancreatitis	0.00213	0.0106	CcSEcCtD
Paliperidone—Hypoglycaemia—Hyoscyamine—pancreatitis	0.0021	0.0104	CcSEcCtD
Paliperidone—Lethargy—Hyoscyamine—pancreatitis	0.0021	0.0104	CcSEcCtD
Paliperidone—Osteoarthritis—Hyoscyamine—pancreatitis	0.00205	0.0102	CcSEcCtD
Paliperidone—Dry mouth—Propantheline—pancreatitis	0.00201	0.00996	CcSEcCtD
Paliperidone—Confusional state—Propantheline—pancreatitis	0.00199	0.00985	CcSEcCtD
Paliperidone—Anaphylactic shock—Propantheline—pancreatitis	0.00197	0.00977	CcSEcCtD
Paliperidone—Cardiac arrest—Hyoscyamine—pancreatitis	0.00195	0.00967	CcSEcCtD
Paliperidone—Urinary retention—Hyoscyamine—pancreatitis	0.00195	0.00967	CcSEcCtD
Paliperidone—Tachycardia—Propantheline—pancreatitis	0.00192	0.00953	CcSEcCtD
Paliperidone—Dry skin—Hyoscyamine—pancreatitis	0.00188	0.00932	CcSEcCtD
Paliperidone—Risperidone—HTR2A—pancreatitis	0.00185	0.516	CrCbGaD
Paliperidone—Insomnia—Propantheline—pancreatitis	0.00178	0.00883	CcSEcCtD
Paliperidone—Dysphagia—Hyoscyamine—pancreatitis	0.00177	0.00879	CcSEcCtD
Paliperidone—Somnolence—Propantheline—pancreatitis	0.00175	0.00868	CcSEcCtD
Paliperidone—Iloperidone—HTR2A—pancreatitis	0.00174	0.484	CrCbGaD
Paliperidone—Constipation—Propantheline—pancreatitis	0.00169	0.00835	CcSEcCtD
Paliperidone—Dysuria—Hyoscyamine—pancreatitis	0.00166	0.00822	CcSEcCtD
Paliperidone—Erectile dysfunction—Hyoscyamine—pancreatitis	0.00163	0.0081	CcSEcCtD
Paliperidone—Feeling abnormal—Propantheline—pancreatitis	0.00162	0.00805	CcSEcCtD
Paliperidone—Hyperglycaemia—Hyoscyamine—pancreatitis	0.0016	0.00793	CcSEcCtD
Paliperidone—Depression—Hyoscyamine—pancreatitis	0.00158	0.00782	CcSEcCtD
Paliperidone—Urticaria—Propantheline—pancreatitis	0.00157	0.00776	CcSEcCtD
Paliperidone—Conjunctivitis—Hyoscyamine—pancreatitis	0.00154	0.00762	CcSEcCtD
Paliperidone—Hypersensitivity—Propantheline—pancreatitis	0.00145	0.00719	CcSEcCtD
Paliperidone—Bradycardia—Hyoscyamine—pancreatitis	0.00145	0.00716	CcSEcCtD
Paliperidone—Asthenia—Propantheline—pancreatitis	0.00141	0.00701	CcSEcCtD
Paliperidone—Flushing—Hyoscyamine—pancreatitis	0.00132	0.00653	CcSEcCtD
Paliperidone—Dizziness—Propantheline—pancreatitis	0.0013	0.00646	CcSEcCtD
Paliperidone—Vomiting—Propantheline—pancreatitis	0.00125	0.00621	CcSEcCtD
Paliperidone—Mental disorder—Hyoscyamine—pancreatitis	0.00124	0.00616	CcSEcCtD
Paliperidone—Rash—Propantheline—pancreatitis	0.00124	0.00616	CcSEcCtD
Paliperidone—Dermatitis—Propantheline—pancreatitis	0.00124	0.00615	CcSEcCtD
Paliperidone—Erythema—Hyoscyamine—pancreatitis	0.00124	0.00613	CcSEcCtD
Paliperidone—Headache—Propantheline—pancreatitis	0.00123	0.00612	CcSEcCtD
Paliperidone—Tension—Hyoscyamine—pancreatitis	0.00121	0.00601	CcSEcCtD
Paliperidone—Dysgeusia—Hyoscyamine—pancreatitis	0.00121	0.006	CcSEcCtD
Paliperidone—Nervousness—Hyoscyamine—pancreatitis	0.0012	0.00595	CcSEcCtD
Paliperidone—Nausea—Propantheline—pancreatitis	0.00117	0.0058	CcSEcCtD
Paliperidone—Vision blurred—Hyoscyamine—pancreatitis	0.00117	0.00577	CcSEcCtD
Paliperidone—Agitation—Hyoscyamine—pancreatitis	0.00114	0.00563	CcSEcCtD
Paliperidone—Angioedema—Hyoscyamine—pancreatitis	0.00113	0.0056	CcSEcCtD
Paliperidone—Vertigo—Hyoscyamine—pancreatitis	0.00111	0.0055	CcSEcCtD
Paliperidone—Syncope—Hyoscyamine—pancreatitis	0.00111	0.00549	CcSEcCtD
Paliperidone—Palpitations—Hyoscyamine—pancreatitis	0.00109	0.00541	CcSEcCtD
Paliperidone—Loss of consciousness—Hyoscyamine—pancreatitis	0.00109	0.00538	CcSEcCtD
Paliperidone—Convulsion—Hyoscyamine—pancreatitis	0.00107	0.00531	CcSEcCtD
Paliperidone—Chest pain—Hyoscyamine—pancreatitis	0.00105	0.00521	CcSEcCtD
Paliperidone—Anxiety—Hyoscyamine—pancreatitis	0.00105	0.0052	CcSEcCtD
Paliperidone—Dry mouth—Hyoscyamine—pancreatitis	0.00103	0.0051	CcSEcCtD
Paliperidone—Confusional state—Hyoscyamine—pancreatitis	0.00102	0.00504	CcSEcCtD
Paliperidone—Oedema—Hyoscyamine—pancreatitis	0.00101	0.005	CcSEcCtD
Paliperidone—Anaphylactic shock—Hyoscyamine—pancreatitis	0.00101	0.005	CcSEcCtD
Paliperidone—Shock—Hyoscyamine—pancreatitis	0.000993	0.00492	CcSEcCtD
Paliperidone—Tachycardia—Hyoscyamine—pancreatitis	0.000985	0.00488	CcSEcCtD
Paliperidone—Hypotension—Hyoscyamine—pancreatitis	0.000943	0.00467	CcSEcCtD
Paliperidone—Insomnia—Hyoscyamine—pancreatitis	0.000913	0.00452	CcSEcCtD
Paliperidone—Dyspnoea—Hyoscyamine—pancreatitis	0.0009	0.00446	CcSEcCtD
Paliperidone—Somnolence—Hyoscyamine—pancreatitis	0.000897	0.00444	CcSEcCtD
Paliperidone—Dyspepsia—Hyoscyamine—pancreatitis	0.000888	0.0044	CcSEcCtD
Paliperidone—Fatigue—Hyoscyamine—pancreatitis	0.00087	0.00431	CcSEcCtD
Paliperidone—Pain—Hyoscyamine—pancreatitis	0.000863	0.00427	CcSEcCtD
Paliperidone—Constipation—Hyoscyamine—pancreatitis	0.000863	0.00427	CcSEcCtD
Paliperidone—Feeling abnormal—Hyoscyamine—pancreatitis	0.000832	0.00412	CcSEcCtD
Paliperidone—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.000825	0.00409	CcSEcCtD
Paliperidone—Urticaria—Hyoscyamine—pancreatitis	0.000802	0.00397	CcSEcCtD
Paliperidone—Body temperature increased—Hyoscyamine—pancreatitis	0.000798	0.00395	CcSEcCtD
Paliperidone—Abdominal pain—Hyoscyamine—pancreatitis	0.000798	0.00395	CcSEcCtD
Paliperidone—Hypersensitivity—Hyoscyamine—pancreatitis	0.000743	0.00368	CcSEcCtD
Paliperidone—Asthenia—Hyoscyamine—pancreatitis	0.000724	0.00359	CcSEcCtD
Paliperidone—Pruritus—Hyoscyamine—pancreatitis	0.000714	0.00354	CcSEcCtD
Paliperidone—Diarrhoea—Hyoscyamine—pancreatitis	0.00069	0.00342	CcSEcCtD
Paliperidone—Dizziness—Hyoscyamine—pancreatitis	0.000667	0.00331	CcSEcCtD
Paliperidone—Vomiting—Hyoscyamine—pancreatitis	0.000642	0.00318	CcSEcCtD
Paliperidone—Rash—Hyoscyamine—pancreatitis	0.000636	0.00315	CcSEcCtD
Paliperidone—Dermatitis—Hyoscyamine—pancreatitis	0.000636	0.00315	CcSEcCtD
Paliperidone—Headache—Hyoscyamine—pancreatitis	0.000632	0.00313	CcSEcCtD
Paliperidone—Nausea—Hyoscyamine—pancreatitis	0.000599	0.00297	CcSEcCtD
Paliperidone—DRD4—Signaling by GPCR—KRAS—pancreatitis	1.61e-05	7.68e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—LEP—pancreatitis	1.6e-05	7.65e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—LEP—pancreatitis	1.59e-05	7.61e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—INS—pancreatitis	1.59e-05	7.6e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—SPP1—pancreatitis	1.59e-05	7.59e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—INS—pancreatitis	1.58e-05	7.56e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—CXCL8—pancreatitis	1.58e-05	7.56e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—INS—pancreatitis	1.57e-05	7.5e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CCL2—pancreatitis	1.57e-05	7.48e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—SPP1—pancreatitis	1.56e-05	7.47e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—SPP1—pancreatitis	1.56e-05	7.45e-05	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—CXCL8—pancreatitis	1.56e-05	7.45e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—CXCL8—pancreatitis	1.56e-05	7.44e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—CXCL8—pancreatitis	1.55e-05	7.42e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—LEP—pancreatitis	1.55e-05	7.4e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CCL2—pancreatitis	1.54e-05	7.38e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCL5—pancreatitis	1.54e-05	7.34e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SPP1—pancreatitis	1.53e-05	7.31e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—MDM2—pancreatitis	1.53e-05	7.29e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—LEP—pancreatitis	1.53e-05	7.29e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—CXCL8—pancreatitis	1.52e-05	7.28e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—HTR2A—pancreatitis	1.51e-05	7.23e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—LPL—pancreatitis	1.5e-05	7.17e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—NRAS—pancreatitis	1.5e-05	7.15e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—MDM2—pancreatitis	1.49e-05	7.14e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—GCG—pancreatitis	1.49e-05	7.12e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—HTR2A—pancreatitis	1.49e-05	7.09e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—MDM2—pancreatitis	1.47e-05	7.02e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—HTR2A—pancreatitis	1.46e-05	6.96e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PLA2G1B—pancreatitis	1.46e-05	6.96e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—ALB—pancreatitis	1.45e-05	6.93e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—HRAS—pancreatitis	1.45e-05	6.92e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—KRAS—pancreatitis	1.45e-05	6.91e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—NRAS—pancreatitis	1.45e-05	6.9e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—NRAS—pancreatitis	1.44e-05	6.87e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—KRAS—pancreatitis	1.43e-05	6.82e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CXCL8—pancreatitis	1.43e-05	6.82e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SPP1—pancreatitis	1.42e-05	6.79e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—HRAS—pancreatitis	1.42e-05	6.77e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—INS—pancreatitis	1.42e-05	6.77e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—CXCL8—pancreatitis	1.42e-05	6.76e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—A2M—pancreatitis	1.41e-05	6.72e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—LEP—pancreatitis	1.41e-05	6.72e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—NRAS—pancreatitis	1.4e-05	6.68e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CXCL8—pancreatitis	1.4e-05	6.67e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CCL2—pancreatitis	1.39e-05	6.66e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—HRAS—pancreatitis	1.39e-05	6.63e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—LEP—pancreatitis	1.38e-05	6.61e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—LEP—pancreatitis	1.38e-05	6.6e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—NRAS—pancreatitis	1.38e-05	6.58e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CXCL8—pancreatitis	1.37e-05	6.57e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—INS—pancreatitis	1.37e-05	6.54e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—HRAS—pancreatitis	1.37e-05	6.53e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CASP3—pancreatitis	1.37e-05	6.52e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—INS—pancreatitis	1.36e-05	6.5e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—IL6—pancreatitis	1.36e-05	6.48e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—LEP—pancreatitis	1.35e-05	6.47e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—HTR2A—pancreatitis	1.35e-05	6.47e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CCL2—pancreatitis	1.35e-05	6.43e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CCL2—pancreatitis	1.34e-05	6.4e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CASP3—pancreatitis	1.34e-05	6.39e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—IL6—pancreatitis	1.33e-05	6.35e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—INS—pancreatitis	1.32e-05	6.32e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MDM2—pancreatitis	1.32e-05	6.32e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CASP3—pancreatitis	1.32e-05	6.29e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PPARG—pancreatitis	1.31e-05	6.26e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—IL6—pancreatitis	1.31e-05	6.25e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MDM2—pancreatitis	1.31e-05	6.24e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—INS—pancreatitis	1.3e-05	6.22e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CCL2—pancreatitis	1.3e-05	6.22e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—KRAS—pancreatitis	1.29e-05	6.16e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ALDH2—pancreatitis	1.29e-05	6.15e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—INS—pancreatitis	1.29e-05	6.14e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CCL2—pancreatitis	1.28e-05	6.12e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PTGS2—pancreatitis	1.27e-05	6.07e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—NRAS—pancreatitis	1.27e-05	6.06e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—LEP—pancreatitis	1.26e-05	6.01e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—NRAS—pancreatitis	1.25e-05	5.96e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—NRAS—pancreatitis	1.25e-05	5.95e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—KRAS—pancreatitis	1.24e-05	5.94e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CXCL8—pancreatitis	1.24e-05	5.91e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—KRAS—pancreatitis	1.24e-05	5.91e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—HRAS—pancreatitis	1.23e-05	5.87e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—NRAS—pancreatitis	1.22e-05	5.84e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CXCL8—pancreatitis	1.22e-05	5.83e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—HRAS—pancreatitis	1.21e-05	5.8e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—KRAS—pancreatitis	1.2e-05	5.75e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PPARG—pancreatitis	1.2e-05	5.74e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—INS—pancreatitis	1.2e-05	5.74e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—KRAS—pancreatitis	1.18e-05	5.66e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CASP3—pancreatitis	1.18e-05	5.66e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—INS—pancreatitis	1.18e-05	5.65e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCL2—pancreatitis	1.18e-05	5.65e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—INS—pancreatitis	1.18e-05	5.63e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MDM2—pancreatitis	1.18e-05	5.63e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—ALB—pancreatitis	1.18e-05	5.63e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—INS—pancreatitis	1.18e-05	5.63e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—IL6—pancreatitis	1.18e-05	5.62e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—LPL—pancreatitis	1.17e-05	5.59e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CASP3—pancreatitis	1.17e-05	5.58e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCL2—pancreatitis	1.16e-05	5.56e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—IL6—pancreatitis	1.16e-05	5.55e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCL2—pancreatitis	1.16e-05	5.54e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—INS—pancreatitis	1.16e-05	5.53e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—NRAS—pancreatitis	1.14e-05	5.47e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCL2—pancreatitis	1.14e-05	5.44e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MDM2—pancreatitis	1.14e-05	5.44e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—NRAS—pancreatitis	1.14e-05	5.43e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MDM2—pancreatitis	1.13e-05	5.41e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—NRAS—pancreatitis	1.12e-05	5.35e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—NRAS—pancreatitis	1.1e-05	5.27e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CXCL8—pancreatitis	1.1e-05	5.27e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MDM2—pancreatitis	1.1e-05	5.26e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—HRAS—pancreatitis	1.1e-05	5.23e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—KRAS—pancreatitis	1.09e-05	5.22e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MDM2—pancreatitis	1.08e-05	5.18e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—ALB—pancreatitis	1.08e-05	5.16e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—INS—pancreatitis	1.08e-05	5.14e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—KRAS—pancreatitis	1.07e-05	5.13e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—KRAS—pancreatitis	1.07e-05	5.12e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CXCL8—pancreatitis	1.06e-05	5.08e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TGFB1—pancreatitis	1.06e-05	5.08e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CXCL8—pancreatitis	1.06e-05	5.06e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCL2—pancreatitis	1.06e-05	5.05e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—HRAS—pancreatitis	1.06e-05	5.05e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CASP3—pancreatitis	1.06e-05	5.04e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—KRAS—pancreatitis	1.05e-05	5.03e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—HRAS—pancreatitis	1.05e-05	5.03e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL6—pancreatitis	1.05e-05	5.01e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TGFB1—pancreatitis	1.04e-05	4.98e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PTGS2—pancreatitis	1.03e-05	4.93e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CXCL8—pancreatitis	1.03e-05	4.92e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TGFB1—pancreatitis	1.02e-05	4.9e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—HRAS—pancreatitis	1.02e-05	4.89e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CASP3—pancreatitis	1.02e-05	4.87e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CXCL8—pancreatitis	1.01e-05	4.84e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CASP3—pancreatitis	1.01e-05	4.84e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL6—pancreatitis	1.01e-05	4.83e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—HRAS—pancreatitis	1.01e-05	4.81e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL6—pancreatitis	1.01e-05	4.81e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MDM2—pancreatitis	9.99e-06	4.77e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—NRAS—pancreatitis	9.93e-06	4.74e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CASP3—pancreatitis	9.86e-06	4.71e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—KRAS—pancreatitis	9.85e-06	4.71e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MDM2—pancreatitis	9.83e-06	4.7e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MDM2—pancreatitis	9.81e-06	4.69e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—NRAS—pancreatitis	9.8e-06	4.68e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL6—pancreatitis	9.79e-06	4.68e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—KRAS—pancreatitis	9.78e-06	4.67e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GCG—pancreatitis	9.75e-06	4.66e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CASP3—pancreatitis	9.7e-06	4.63e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—KRAS—pancreatitis	9.65e-06	4.61e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL6—pancreatitis	9.64e-06	4.6e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MDM2—pancreatitis	9.63e-06	4.6e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—KRAS—pancreatitis	9.49e-06	4.53e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PTGS2—pancreatitis	9.45e-06	4.52e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CXCL8—pancreatitis	9.34e-06	4.46e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—HRAS—pancreatitis	9.28e-06	4.44e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TGFB1—pancreatitis	9.23e-06	4.41e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CXCL8—pancreatitis	9.19e-06	4.39e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CXCL8—pancreatitis	9.17e-06	4.38e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—HRAS—pancreatitis	9.13e-06	4.36e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—HRAS—pancreatitis	9.12e-06	4.35e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TGFB1—pancreatitis	9.1e-06	4.35e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CXCL8—pancreatitis	9e-06	4.3e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MDM2—pancreatitis	8.95e-06	4.27e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—HRAS—pancreatitis	8.94e-06	4.27e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CASP3—pancreatitis	8.94e-06	4.27e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL6—pancreatitis	8.89e-06	4.24e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—NRAS—pancreatitis	8.84e-06	4.23e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CASP3—pancreatitis	8.8e-06	4.2e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CASP3—pancreatitis	8.78e-06	4.19e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL6—pancreatitis	8.74e-06	4.18e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL6—pancreatitis	8.72e-06	4.17e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CASP3—pancreatitis	8.62e-06	4.12e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL6—pancreatitis	8.56e-06	4.09e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—KRAS—pancreatitis	8.55e-06	4.08e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PPARG—pancreatitis	8.54e-06	4.08e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—NRAS—pancreatitis	8.54e-06	4.08e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—NRAS—pancreatitis	8.49e-06	4.06e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—KRAS—pancreatitis	8.43e-06	4.03e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—INS—pancreatitis	8.38e-06	4e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—HRAS—pancreatitis	8.37e-06	4e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CXCL8—pancreatitis	8.36e-06	4e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—HRAS—pancreatitis	8.31e-06	3.97e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—NRAS—pancreatitis	8.26e-06	3.95e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TGFB1—pancreatitis	8.22e-06	3.93e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—HRAS—pancreatitis	8.2e-06	3.92e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—NRAS—pancreatitis	8.13e-06	3.88e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—HRAS—pancreatitis	8.07e-06	3.85e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL6—pancreatitis	8.02e-06	3.83e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CASP3—pancreatitis	8.01e-06	3.82e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL6—pancreatitis	7.95e-06	3.8e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TGFB1—pancreatitis	7.93e-06	3.79e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TGFB1—pancreatitis	7.89e-06	3.77e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL6—pancreatitis	7.85e-06	3.75e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL6—pancreatitis	7.72e-06	3.69e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ALB—pancreatitis	7.68e-06	3.67e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TGFB1—pancreatitis	7.68e-06	3.67e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—LPL—pancreatitis	7.65e-06	3.66e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—KRAS—pancreatitis	7.61e-06	3.64e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TGFB1—pancreatitis	7.56e-06	3.61e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NRAS—pancreatitis	7.5e-06	3.58e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NRAS—pancreatitis	7.38e-06	3.52e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NRAS—pancreatitis	7.36e-06	3.52e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—KRAS—pancreatitis	7.35e-06	3.51e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—KRAS—pancreatitis	7.31e-06	3.49e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—HRAS—pancreatitis	7.26e-06	3.47e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NRAS—pancreatitis	7.22e-06	3.45e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—HRAS—pancreatitis	7.17e-06	3.42e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—KRAS—pancreatitis	7.11e-06	3.4e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—KRAS—pancreatitis	7e-06	3.34e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TGFB1—pancreatitis	6.97e-06	3.33e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL6—pancreatitis	6.95e-06	3.32e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL6—pancreatitis	6.86e-06	3.28e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TGFB1—pancreatitis	6.85e-06	3.27e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TGFB1—pancreatitis	6.84e-06	3.27e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTGS2—pancreatitis	6.72e-06	3.21e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TGFB1—pancreatitis	6.71e-06	3.21e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NRAS—pancreatitis	6.71e-06	3.21e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—HRAS—pancreatitis	6.47e-06	3.09e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—KRAS—pancreatitis	6.45e-06	3.08e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—KRAS—pancreatitis	6.35e-06	3.03e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—KRAS—pancreatitis	6.33e-06	3.03e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—HRAS—pancreatitis	6.25e-06	2.98e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TGFB1—pancreatitis	6.24e-06	2.98e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—KRAS—pancreatitis	6.22e-06	2.97e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—HRAS—pancreatitis	6.21e-06	2.97e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL6—pancreatitis	6.19e-06	2.96e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—HRAS—pancreatitis	6.04e-06	2.89e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL6—pancreatitis	5.98e-06	2.86e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—HRAS—pancreatitis	5.95e-06	2.84e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL6—pancreatitis	5.95e-06	2.84e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL6—pancreatitis	5.79e-06	2.76e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—KRAS—pancreatitis	5.78e-06	2.76e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL6—pancreatitis	5.69e-06	2.72e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARG—pancreatitis	5.59e-06	2.67e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—HRAS—pancreatitis	5.48e-06	2.62e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—INS—pancreatitis	5.48e-06	2.62e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—HRAS—pancreatitis	5.4e-06	2.58e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—HRAS—pancreatitis	5.38e-06	2.57e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—HRAS—pancreatitis	5.28e-06	2.52e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL6—pancreatitis	5.25e-06	2.51e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6—pancreatitis	5.16e-06	2.47e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6—pancreatitis	5.15e-06	2.46e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6—pancreatitis	5.06e-06	2.42e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ALB—pancreatitis	5.02e-06	2.4e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—HRAS—pancreatitis	4.91e-06	2.35e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6—pancreatitis	4.7e-06	2.24e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTGS2—pancreatitis	4.39e-06	2.1e-05	CbGpPWpGaD
